Welcome to visit Zhongnan Medical Journal Press Series journal website!

Consistency of ultrasonography and magnetic resonance imaging in measuring prostate size and volume

Published on Jun. 01, 2024Total Views: 257 timesTotal Downloads: 216 timesDownloadMobile

Author: MAO Xiaoli 1 ZI Hao 2, 3 ZHANG Jie 4 LIU Shuangtai 2 HUANG Qiao 3 LI Binghui 3 ZENG Xiantao 3

Affiliation: 1. Department of Ultrasonography, Wuhan Institute of Technology Hospital, Wuhan 430074, China 2. Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China 3. Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China 4. Department of Retirement Affairs, Zhongnan Hospital of Wuhan University, Wuhan 430071, China

Keywords: Benign prostatic hyperplasia Prostate Size Volume Ultrasonography Magnetic resonance imaging Consistency

DOI: 10.12173/j.issn.1004-5511.202404017

Reference: Mao XL, Zi H, Zhang J, Liu ST, Huang Q, Li BH, Zeng XT. Consistency of ultrasonography and magnetic resonance imaging in measuring prostate size and volume[J]. Yixue Xinzhi Zazhi, 2024, 34(5): 530-537. DOI: 10.12173/j.issn.1004-5511.202404017. [Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

Objective  To evaluate the consistency of ultrasonography and magnetic resonance imaging (MRI) in measuring of prostate size and volume.

Methods  The data of this study was from the research data of the bladder cancer and benign prostatic hyperplasia study in Chinese population. The study examined the prostates of participants using both ultrasonography and MRI. Prostate size was measured by the transverse diameter, antero-posterior diameter, and supero-inferior diameter, and volume was calculated using a formula. Groups comparisons were conducted using Wilcoxon signed rank test and the consistency of measurement results was evaluated using Bland-Altman analysis.

Results  103 patients with benign prostatic hyperplasia were included. The mean transverse diameter, mean antero-posterior diameter, and mean supero-inferior diameter of the prostate measured by ultrasonography was (5.789±0.835) cm, (5.054±0.915) cm, and (4.530±0.882) cm respectively, and the median volume was 66.690(49.179, 96.110) mL. The median transverse diameter, median antero-posterior diameter and median supero-inferior diameter of the prostate measured by MRI was 5.800(5.300, 6.400) cm, 5.000(4.650, 5.600) cm, and 4.300(3.900, 4.800) cm respectively, and the median volume was 65.520(49.678, 90.714) mL. The prostate size results had good agreement between ultrasound and MRI measurements, with no statistical difference between the two measurements. The prostate volume measured by ultrasonography had a small deviation compared to the MRI measurement, with an average difference of 1.329 mL. Conclusion  The consistency between ultrasonography and MRI in measuring prostate size and volume is strong. In clinical practice, the appropriate method for measuring prostate size and volume should be chosen based on the specific circumstances.

Full-text
Please download the PDF version to read the full text: download
References

1. 阎思宇, 黄兴, 陈征, 等. 良性前列腺增生经尿道前列腺等离子电切术临床路径释义[J]. 医学新知, 2022, 32(3): 214-222. [Yan SY, Huang X, Chen Z, et al. Clinical pathway interpretation of transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia[J]. Yixue Xinzhi Zazhi, 2022, 32(3): 214-222.] DOI: 10.12173/j.issn.1004-5511.202205003.

2. 顾佳敏, 朱聪, 訾豪, 等. 1990-2019年中国良性前列腺增生疾病负担分析[J]. 解放军医学杂志, 2021, 46(10): 984-988. [Gu JM, Zhu C, Zi H, et al. Analysis of the disease burden of benign prostatic hyperplasia in China from 1990 to 2019[J]. Medical Journal of Chinese People's Liberation Army, 2021, 46(10): 984-988.] DOI: 10.11855/j.issn.0577-7402.2021.10.05.

3. 罗丽莎, 栾航航, 朱聪, 等. 1990-2019年中国、日本与韩国的良性前列腺增生疾病负担比较[J]. 现代泌尿外科杂志, 2023, 28(6): 506-512. [Luo LS, Luan HH, Zhu C, et al. Disease burden of benign prostatic hyperplasia in China, Japan and South Korea from 1990 to 2019: a comparative study[J]. Journal of Modern Urology, 2023, 28(6): 506-512.] DOI: 10.3969/j.issn.1009-8291. 2023.06.010.

4. Zhu C, Wang DQ, Zi H, et al. Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019[J]. Mil Med Res, 2021, 8(1): 64. DOI: 10.1186/s40779-021-00359-8.

5. 钱信行, 顾佳敏, 陆沛文, 等. 良性前列腺增生多组学生物标志物的研究进展[J]. 医学新知, 2024, 34(2): 206-216. [Qian XH, Gu JM, Lu PW, et al. The research progress on multi-omics analysis biomarkers of benign prostatic hyperplasia[J]. Yixue Xinzhi Zazhi, 2024, 34(2): 206-216.] DOI: 10.12173/j.issn.1004-5511.202312069.

6. 杨室淞, 朱聪, 钱信行, 等. 良性前列腺增生与牙周炎[J]. 医学新知, 2024, 34(3): 330-338. [Yang SS, Zhu C, Qian XH, et al. Benign prostatic hyperplasia and periodontitis[J]. Yixue Xinzhi Zazhi, 2024, 34(3): 330-338.] DOI: 10.12173/j.issn.1004-5511.202402025.

7. Gravas S, Gacci M, Gratzke C, et al. Summary paper on the 2023 European association of urology guidelines on the management of non-neurogenic male lower urinary tract symptoms[J]. Eur Urol, 2023, 84(2): 207-222. DOI: 10.1016/j.eururo.2023.04.008.

8. 汪香玉, 覃涛. 扩散峰度成像在前列腺疾病诊断中的临床应用进展[J]. 临床放射学杂志, 2018, 37(5): 886-887. [Wang XY, Qin T. Progress in the clinical application of diffusion kurtosis imaging in the diagnosis of prostate diseases[J]. Journal of Clinical Radiology, 2018, 37(5): 886-887.] DOI: 10.13437/j.cnki.jcr.2018.05.043.

9. 杨小芹. B超测定良性前列腺增生(BPH)患者膀胱内前列腺突入程度(IPP)的临床价值分析[J]. 当代医学, 2021, 27(12): 137-138. [Yang XQ. Clinical value analysis of B-ultraaonography on intravesical prostate penetration (IPP) in patients with benign prostatic hyperplasia (BPH) [J]. Contemporary Medicine, 2021, 27(12): 137-138.] DOI: 10.3969/j.issn.1009-4393.2021.12.056.

10. 王利君, 张燕, 王璐, 等. 动态增强磁共振成像技术在子宫颈癌临床分期中的应用[J]. 数理医药学杂志, 2023, 36(9): 664-670. [Wang LJ, Zhang Y, Wang  L, et al. Application of dynamic contrast-enhanced MRI technology in clinical staging of cervical cancer[J]. Journal of Mathematical Medicine, 2023, 36(9): 664-670.] DOI: 10.12173/j.issn.1004-4337.202307034.

11. 付瑜莹, 付振杰. MRI在前列腺疾病诊断中的应用价值[J]. 中国实用医药, 2016, 11(21): 78-79. [Fu YY, Fu ZJ. The application value of MRI in the diagnosis of prostate diseases[J]. China Practical Medicine, 2016, 11(21): 78-79.] DOI: 10.14163/j.cnki.11-5547/r.2016.21.051.

12. Paterson NR, Lavallee LT, Nguyen LN, et al. Prostate volume estimations using magnetic resonance imaging and transrectal ultrasound compared to radical prostatectomy specimens[J]. Can Urol Assoc J, 2016, 10(7-8): 264-268. DOI: 10.5489/cuaj.3236.

13. Zeng XT, Liu TZ, Gong K, et al. The BPSC: a prospective study investigating the clinical effect of interventional therapy and the risk factors for bladder cancer and benign prostatic hyperplasia in Chinese population[J]. J Evid Based Med, 2018, 11(1): 64-67. DOI: 10.1111/jebm.12290.

14. Tewari A, Indudhara R, Shinohara K, et al. Comparison of transrectal ultrasound prostatic volume estimation with magnetic resonance imaging volume estimation and surgical specimen weight in patients with benign prostatic hyperplasia[J]. J Clin Ultrasound, 1996, 24(4): 169-174. DOI: 10.1002/(SICI)1097-0096(199605)24:4<169::AID-JCU2>3.0.CO;2-D.

15. 骆万超, 温红, 罗欢嘉, 等. 经直肠超声测量前列腺体积对游离前列腺特异性抗原密度预测前列腺癌的临床意义[J]. 现代泌尿外科杂志, 2023, 28(7): 623-626. [Luo WC, Wen H, Luo HJ, et al. Clinical significance of transrectal ultrasound measurement of prostate volume in predicting prostate cancer by free prostate specific antigen density[J]. Journal of Modern Urology, 2023, 28(7): 623-626.] DOI: 10.3969/j.issn.1009-8291.2023.07.016.

16. Udo CO, Robinson ED, Ijeruh OY, et al. Correlation between transabdominal sonographic prostate volume and anthropometric parameters[J]. J Med Ultrasound, 2022, 30(4): 261-265. DOI: 10.4103/jmu.jmu_183_21.

17. 宋现霞. 经直肠前列腺彩色多普勒超声检查[J]. 中国农村卫生, 2018, (10): 79. [Song XX. Transrectal color doppler ultrasound of the prostate[J]. China Rural Health, 2018, (10): 79.] DOI: 10.3969/j.issn.1674-361X.2018.10.080.

18. 叶一使, 张伟丽, 陈淑秀. 经腹部超声与经直肠超声在良性前列腺增生的诊断差异[J]. 现代医用影像学, 2022, 31(1): 183-185. [Ye YS, Zhang WL, Chen SX. Differences between transabdominal ultrasound and transrectal ultrasound in the diagnosis of benign prostatic hyperplasia[J]. Modern Medical Imageology, 2022, 31(1): 183-185.] DOI: 10.3969/j.issn.1006-7035.2022.01.055.

19. Wasserman NF, Niendorf E, Spilseth B. Measurement of prostate volume with MRI (a guide for the perplexed): biproximate method with analysis of precision and accuracy[J]. Sci Rep, 2020, 10(1): 575. DOI: 10.1038/s41598-019-57046-x.

20. 王爱杰, 和一帆, 王春业, 等. 高分辨率磁共振血管壁成像对芪龙胶囊联合西药治疗症状性颈动脉易损斑块的疗效评估[J]. 数理医药学杂志, 2023, 36(10): 754-761. [Wang AJ, He YF, Wang CY, et al. The value of HRMR-VWI in assessing the effect of Qilong capsule combined with Western medicine in the treatment of symptomatic vulnerable carotid plaque[J]. Journal of Mathematical Medicine, 2023, 36(10): 754-761.] DOI: 10.12173/j.issn.1004-4337.202308124.

21. Hamzaoui D, Montagne S, Granger B, et al. Prostate volume prediction on MRI: tools, accuracy and variability[J]. Eur Radiol, 2022, 32(7): 4931-4941. DOI: 10.1007/s00330-022-08554-4.

22. 侯佳丽, 马文亮, 董翔, 等. 基于前列腺超声和磁共振测算前列腺体积方法的准确性研究[J]. 中华男科学杂志, 2022, 28(10): 896-900. [Hou JL, Ma WL, Dong X, et al. Accuracy of prostatic ultrasonography versus MRl in measuring prostate volume[J]. National Journal of Andrology, 2022, 28(10): 896-900.] DOI: 10.13263/j.cnki.nja.2022.10.006.

23. Guo SK, Zhang JJ, Jiao JH, et al. Comparison of prostate volume measured by transabdominal ultrasound and MRI with the radical prostatectomy specimen volume: a retrospective observational study[J]. BMC Urol, 2023, 23(1): 62. DOI: 10.1186/s12894-023-01234-5.

24. Boschheidgen M, Schimmöller L, Arsov C, et al. MRI grading for the prediction of prostate cancer aggressiveness[J]. Eur Radiol, 2022, 32(4): 2351-2359. DOI: 10.1007/s00330-021-08332-8.

25. 吴仲致, 黄君. 前列腺疾病使用腹部超声与直肠超声的诊断比较[J]. 河北医药, 2012, 34(14): 2112-2113. [Wu ZZ, Huang J. Comparison of abdominal and rectal ultrasound in the diagnosis of prostate disease[J]. Hebei Medical Journal, 2012, 34(14): 2112-2113.] DOI: 10.3969/j.issn.1002-7386.2012.14.014.

26. 胡赛峰, 胡安定, 钱挺照. 坦索罗辛与阿夫唑嗪对良性前列腺增生患者生活质量和性功能的影响[J]. 中国药师, 2023, 26(10): 111-118. [Hu SF, Hu AD, Qian TZ. Effects of tamsulosin and alfuzosin on quality of life and sexual function in patients with benign prostatic hyperplasia[J]. China Pharmacist, 2023, 26(10): 111-118.] DOI: 10.12173/j.issn.1008-049X.202310112.

27. 袁为标, 陆大军, 李海峰, 等. 基于磁共振表观扩散系数图像的影像组学模型对鉴别前列腺癌和前列腺增生的价值[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(1): 14-18. [Yuan WB, Lu DJ, Li HF, et al. Apparent diffusion coefficient map based radiomics model in differentiation of prostate cancer and benign prostate hyperplasia[J]. Chinese Journal of Endourology(Electronic Edition), 2022, 16(1): 14-18.] DOI: 10.3877/cma.j.issn.1674-3253.2022.01.003.

28. 罗丽莎, 栾航航, 郑航, 等. 中国1990—2019年归因于吸烟的前列腺癌、膀胱癌和肾癌疾病负担研究[J]. 中国循证医学杂志, 2022, 22(5): 530-536. [Luo LS, Luan HH, Zheng H, et al. An analysis of disease burden of prostate, bladder and kidney cancers attributable to smoking in China from 1990 to 2019[J]. Chinese Journal of Evidence-Based Medicine, 2022, 22(5): 530-536.] DOI: 10.7507/1672-2531.202201059.

29. Aprikian S, Luz M, Brimo F, et al. Improving ultrasound-based prostate volume estimation[J]. BMC Urol, 2019, 19(1): 68. DOI: 10.1186/s12894-019-0492-2.

30. Albayrak NB, Akgul YS. Estimation of the prostate volume from abdominal ultrasound images by image-patch voting[J]. Appl Sci, 2022, 12(3): 1390. DOI: 10.3390/app12031390.